Constantine J Karvellas Selected Research

Acute-On-Chronic Liver Failure

3/2022	Patients With Acute-on-Chronic Liver Failure Have Greater Healthcare Resource Utilization After Liver Transplantation.
1/2022	Risk Factors for Posttransplantation Mortality in Recipients With Grade 3 Acute-on-Chronic Liver Failure: Analysis of a North American Consortium.
1/2021	Liver Transplantation in Acute-on-chronic Liver Failure.
12/2020	Longterm Outcomes of Patients Undergoing Liver Transplantation for Acute-on-Chronic Liver Failure.
10/2020	Patients with severe acute-on-chronic liver failure are disadvantaged by model for end-stage liver disease-based organ allocation policy.
1/2020	Critical care considerations in the management of acute-on-chronic liver failure.
1/2020	Effect of the clinical course of acute-on-chronic liver failure prior to liver transplantation on post-transplant survival.
1/2020	Leucocyte ratios are biomarkers of mortality in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure.
1/2019	Patients With Acute on Chronic Liver Failure Grade 3 Have Greater 14-Day Waitlist Mortality Than Status-1a Patients.
1/2019	Acute kidney injury in cirrhosis: implications for liver transplantation.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Constantine J Karvellas Research Topics

Disease

24	Acute Liver Failure (Fulminant Hepatic Failure) 01/2022 - 06/2007
15	Acute-On-Chronic Liver Failure 03/2022 - 11/2012
13	Fibrosis (Cirrhosis) 05/2022 - 10/2011
12	End Stage Liver Disease 10/2020 - 12/2007
7	Liver Diseases (Liver Disease) 10/2022 - 12/2007
7	Hepatic Encephalopathy 01/2022 - 12/2007
6	Acute Kidney Injury (Acute Renal Failure) 11/2021 - 01/2011
6	Critical Illness (Critically Ill) 01/2021 - 01/2011
5	Coma (Comas) 04/2021 - 08/2013
4	Intracranial Hypertension 12/2021 - 12/2007
4	Hemorrhage 01/2021 - 04/2012
4	Infections 01/2021 - 11/2014
3	Liver Failure 01/2020 - 01/2007
2	Brain Edema (Cerebral Edema) 12/2021 - 10/2017
2	Disease Progression 01/2020 - 01/2017
2	Respiratory Insufficiency (Respiratory Failure) 01/2020 - 01/2017
2	Obesity 12/2019 - 01/2018
2	Necrosis 01/2019 - 11/2012
2	Inflammation (Inflammations) 01/2019 - 11/2012
2	Thrombosis (Thrombus) 01/2018 - 03/2017
2	Sepsis (Septicemia) 11/2014 - 10/2011
1	Wounds and Injuries (Trauma) 01/2022
1	Abdominal Injuries 01/2022
1	Kidney Diseases (Kidney Disease) 01/2022
1	Rare Diseases (Rare Disease) 12/2021
1	Malnutrition (Nutritional Deficiencies) 01/2021
1	Ascites 01/2021
1	Acidosis 03/2020
1	Hepatitis 02/2020
1	Shock 01/2020
1	Body Weight (Weight, Body) 12/2019
1	Atherosclerosis 01/2019
1	Chronic Renal Insufficiency 01/2019
1	Non-alcoholic Fatty Liver Disease 01/2019
1	Dyslipidemias (Dyslipidemia) 01/2019
1	Pneumonia (Pneumonitis) 01/2018
1	Chemical and Drug Induced Liver Injury 01/2018
1	Septic Shock (Toxic Shock Syndrome) 01/2018
1	Overweight 01/2017
1	Hepatorenal Syndrome 10/2016
1	Hypothermia 05/2014
1	Pain (Aches) 04/2014
1	Nausea 04/2014
1	Multiple Organ Failure (MODS) 11/2013
1	Delirium 04/2013
1	Emergence Delirium 04/2013

Drug/Important Bio-Agent (IBA)

18	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2022 - 01/2009
5	Lactic Acid (Lactate)FDA LinkGeneric 01/2022 - 02/2013
4	CreatinineIBA 01/2022 - 04/2012
4	AlbuminsIBA 01/2022 - 01/2007
4	AmmoniaIBA 01/2022 - 12/2007
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 10/2015
3	Proteins (Proteins, Gene)FDA Link 09/2018 - 01/2009
2	Hemostatics (Antihemorrhagics)IBA 10/2022 - 01/2021
2	BilirubinIBA 01/2022 - 04/2021
2	Fatty Acid-Binding ProteinsIBA 01/2021 - 01/2019
2	SodiumIBA 10/2020 - 01/2019
2	Pharmaceutical PreparationsIBA 01/2018 - 07/2010
1	MicroRNAs (MicroRNA)IBA 01/2021
1	ElectrolytesIBA 03/2020
1	Glucose (Dextrose)FDA LinkGeneric 12/2019
1	Interleukin-18 (Interleukin 18)IBA 01/2019
1	Lipocalin-2IBA 01/2019
1	CholesterolIBA 01/2019
1	TerlipressinIBA 01/2019
1	quinone (benzoquinone)IBA 09/2018
1	N-acetyl-4-benzoquinoneimine (NAPQI)IBA 09/2018
1	Human Serum Albumin FDA LinkGeneric 09/2018
1	IminesIBA 09/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	Infliximab (Remicade)FDA Link 01/2018
1	ImmunosorbentsIBA 01/2017
1	EnzymesIBA 01/2017
1	Antiviral Agents (Antivirals)IBA 01/2017
1	Cytidine Triphosphate (CTP)IBA 12/2016
1	C-Reactive ProteinIBA 10/2016
1	amatoxinIBA 01/2016
1	ophthalmic acidIBA 01/2015
1	Mannitol (Osmitrol)FDA LinkGeneric 05/2014
1	CatalaseIBA 11/2013
1	dicarboxydine (DCD)IBA 08/2013
1	Interleukin-2 (IL2)IBA 11/2012
1	ChemokinesIBA 11/2012
1	Chemokine CCL5IBA 11/2012
1	Interleukin-8 (Interleukin 8)IBA 11/2012

Therapy/Procedure

31	Liver Transplantation 10/2022 - 06/2007
9	Artificial Respiration (Mechanical Ventilation) 01/2022 - 04/2014
8	Critical Care (Surgical Intensive Care) 01/2022 - 11/2017
8	Therapeutics 01/2022 - 08/2004
6	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2022 - 01/2010
4	Transplantation 01/2022 - 11/2017
2	Length of Stay 05/2022 - 04/2014
2	Drug Therapy (Chemotherapy) 01/2017 - 08/2004
1	Nutritional Support (Artificial Feeding) 01/2021
1	Nutrition Therapy (Medical Nutrition Therapy) 01/2021
1	Kidney Transplantation 01/2019
1	Continuous Renal Replacement Therapy 01/2018
1	Parenteral Nutrition 01/2017
1	Induced Hypothermia 01/2015
1	Palliative Care (Palliative Therapy) 04/2014